Immunoinflammatory Response in Post Cardiac Arrest Syndrome (PCAS)

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorMaineHealth

About this trial

This is a prospective, observational study to investigate molecular mechanisms mediating the systemic inflammatory process, and changes to metabolism, and their impact on brain injury, survival, and functional outcomes after cardiac arrest. Investigators have shown that cardiac arrest induces changes in the numbers and properties of circulating immune cells, shifting the balance towards a pro-inflammatory phenotype and there is increased interest in the inflammatory pathways and the signaling mechanisms through which they are modulated. Participants will undergo blood sampling during 7 days following cardiac arrest, and analyses performed. Patient characteristics, clinical circumstances, and outcomes will be recorded and their associations with these inflammatory pathways characterized.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Aged 18 years or older

Admitted to the intensive care unit after cardiac arrest episode

Unresponsive after resuscitation

Disqualifiers

Moribund / actively dying at the time of evaluation

Informed consent cannot be obtained within 24 hours of resuscitation

Hemoglobin less than 7.0 g/dL, active high-volume bleeding, or requiring a transfusion

Trial population

Cardiac arrest survivors with encephalopathy admitted to the intensive care unit and unresponsive after resuscitation

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

Not listed

Trial groups

No trial groups listed

Trial outcomes

Primary outcomes

1

Correlations between inflammatory markers and clinical outcomes

Correlations between inflammatory markers and clinical outcomes

Time frame
14 days
2

Correlations between inflammatory markers and biomarkers of neurological and cardiac injury

Correlations between inflammatory markers and biomarkers of neurological and cardiac injury

Time frame
7 days

Secondary outcomes

1

Characterization of post-resuscitation inflammatory mechanisms and their regulators

Characterization of post-resuscitation inflammatory mechanisms and their regulators

Time frame
7 days
2

Brown Fat activity

Correlations between 12,13 diHOME, blood glucose, and outcome

Time frame
2 weeks

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

MaineHealth

Lead sponsor

National Institute of General Medical Sciences (NIGMS)

Collaborator

National Heart, Lung, and Blood Institute (NHLBI)

Collaborator